Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 828.00
Bid: 822.00
Ask: 848.00
Change: 0.00 (0.00%)
Spread: 26.00 (3.163%)
Open: 828.00
High: 0.00
Low: 0.00
Prev. Close: 828.00
MAB1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

24 May 2023 07:00

RNS Number : 4155A
Mortgage Advice Bureau (Hldgs) PLC
24 May 2023
 

24 May 2023

Mortgage Advice Bureau (Holdings) plc ("MAB" or "the Group")

AGM Statement

Mortgage Advice Bureau (Holdings) plc (AIM:MAB1.L) will hold its Annual General Meeting at 2pm today during which the Non-Executive Chair, Katherine Innes Ker, will make the following statement:

"In an ongoing challenging environment, we continue to demonstrate the strength of MAB's model and resilience in adviser numbers and mortgage completions against a significantly weaker market backdrop. This positions the Group well for subsequent market recovery.

"Our Adviser numbers have stabilised in Q2 at 2,1221 advisers on 19 May 2023. We expect our existing Appointed Representative firms to start growing their adviser numbers again later in the year, most likely as consumer confidence improves further when there is more certainty around the outlook for mortgage interest rates and our firms can plan with a greater degree of certainty. Our pipeline of incoming new Appointed Representatives has grown strongly this year.

"As expected, the value of completions in the wider market was slower in Q1 2023 with a 21% reduction in new mortgage lending2 compared to last year. MAB's total mortgage completions for Q1 2023 were broadly stable at £5.8bn (2022: £5.9bn). Our new mortgage completions were £4.4bn (2022: £4.9bn) with the balance of £1.4bn (2022: £1.0bn) being Product Transfers. We have continued to grow our market share, which has been achieved despite a reduction in the number of advisers since Q4 2022.

"During the six months following the mini-budget, new mortgage approvals across the market were down by as much as 40% versus the prior year. There are early signs of increasing activity and mortgage approval levels have now gradually started to improve, but remain significantly lower than for the equivalent period last year.

"MAB's performance, despite challenging market conditions, remains in line with the Board's expectations with further improvement expected in the second-half of the year."

 

1 Includes 139 Fluent advisers as at 19 May 2023 (76 advisers in the first charge mortgages division, 49 in the secured personal loans division, 8 in the later life division, and 6 in the bridging finance division). Includes a total of 183 advisers at 19 May 2023 who are later life advisers or advisers in directly authorised firms that use MAB's subsidiary, Auxilium, a specialist protection service provider, for protection. For both later life and directly authorised advisers the fees received by MAB represent the net income received by MAB as there are no commission payouts made by MAB.

2 UK Finance, product transfer lending figures not available until 7 June.

 

Enquiries:

Mortgage Advice Bureau (Holdings) Plc

Tel: +44 (0) 1332 525007

 

Peter Brodnicki - Chief Executive Officer

Ben Thompson - Deputy Chief Executive Officer

Lucy Tilley - Chief Financial Officer

 

Nominated Adviser and Joint Broker:

Numis Securities Limited

Stephen Westgate / Giles Rolls

 

+44 (0)20 7260 1000

Joint Broker:

Peel Hunt LLP

Andrew Buchanan / Mike Burke

 

+44 (0) 20 7418 8900

Media Enquiries: investor.relations@mab.org.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEDFWDEDSEEI
Date   Source Headline
26th Jul 201912:02 pmRNSPrice Monitoring Extension
25th Jul 20197:00 amRNSTrading Statement
17th Jul 201911:57 amRNSNational Employee Mortgage Advice Service Launch
15th Jul 20193:44 pmRNSDirector/PDMR Shareholding
11th Jul 20195:37 pmRNSHolding(s) in Company
10th Jul 201910:00 amRNSExercise of Options and Director/PDMR Shareholding
8th Jul 201912:07 pmRNSSecond Price Monitoring Extn
8th Jul 201912:02 pmRNSPrice Monitoring Extension
2nd Jul 20198:52 amRNSGrant of options and Director dealing
28th Jun 20193:57 pmRNSDirector/PDMR Shareholding
18th Jun 20197:05 amRNSAcquisition of 80% interest in First Mortgage
14th Jun 20195:40 pmRNSDirector/PDMR Shareholding
31st May 20194:32 pmRNSDirector/PDMR Shareholding
28th May 201910:49 amRNSHolding(s) in Company
21st May 20193:57 pmRNSResult of AGM
21st May 20197:00 amRNSAGM Statement
16th May 20198:34 amRNSDirector/PDMR Shareholding
30th Apr 20192:43 pmRNSDirector/PDMR Shareholding
24th Apr 20197:00 amRNSExecutive Director Updates
16th Apr 20194:57 pmRNSDirector/PDMR Shareholding
15th Apr 20197:00 amRNSPosting of Report and Accounts and Notice of AGM
4th Apr 20194:40 pmRNSSecond Price Monitoring Extn
4th Apr 20194:35 pmRNSPrice Monitoring Extension
29th Mar 201912:10 pmRNSDirector/PDMR Shareholding
29th Mar 20199:33 amRNSBlock Admission Application
21st Mar 20198:13 amRNSHolding(s) in Company
21st Mar 20198:12 amRNSHolding(s) in Company
19th Mar 20197:00 amRNSFinal Results for the year ended 31 December 2018
14th Mar 20194:50 pmRNSDirector/PDMR Shareholding
6th Mar 20197:00 amRNSHolding(s) in Company
5th Mar 201912:13 pmRNSHolding(s) in Company
28th Feb 20191:41 pmRNSDirector/PDMR Shareholding
25th Feb 20194:35 pmRNSPrice Monitoring Extension
21st Feb 20194:59 pmRNSHolding(s) in Company
14th Feb 20195:54 pmRNSDirector/PDMR Shareholding
31st Jan 20194:21 pmRNSDirector/PDMR Shareholding
30th Jan 20198:32 amRNSHolding(s) in Company
25th Jan 201910:39 amRNSNew Investor Website
22nd Jan 20197:00 amRNSTrading Update
21st Jan 20197:00 amRNSDirectorate Change
14th Jan 20195:30 pmRNSFaroe Petroleum
14th Jan 20195:24 pmRNSDirector/PDMR Shareholding
31st Dec 201810:52 amRNSDirector/PDMR Shareholding
17th Dec 20187:02 amRNSDirector/PDMR Shareholding
30th Nov 20181:16 pmRNSDirector/PDMR Shareholding
23rd Nov 20184:35 pmRNSPrice Monitoring Extension
14th Nov 20185:54 pmRNSDirector/PDMR Shareholding
31st Oct 20183:35 pmRNSDirector/PDMR Shareholding
29th Oct 20189:13 amRNSDirector/PDMR Shareholding
23rd Oct 20187:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.